NSABP FB-7: A phase II randomized neoadjuvant trial with paclitaxel + trastuzumab and/or neratinib followed by chemotherapy and postoperative trastuzumab in HER2+ breast cancer

  1. Jacobs, S.A.
  2. Robidoux, A.
  3. Abraham, J.
  4. Pérez-Garcia, J.M.
  5. La Verde, N.
  6. Orcutt, J.M.
  7. Cazzaniga, M.E.
  8. Piette, F.
  9. Antolín, S.
  10. Aguirre, E.
  11. Cortes, J.
  12. Llombart-Cussac, A.
  13. Di Cosimo, S.
  14. Kim, R.S.
  15. Feng, H.
  16. Lipchik, C.
  17. Lucas, P.C.
  18. Srinivasan, A.
  19. Wang, Y.
  20. Song, N.
  21. Gavin, P.G.
  22. Balousek, A.D.
  23. Paik, S.
  24. Allegra, C.J.
  25. Wolmark, N.
  26. Pogue-Geile, K.L.
  27. Show all authors +
Journal:
Breast Cancer Research

ISSN: 1465-542X,  1465-5411

Year of publication: 2019

Volume: 21

Issue: 1

Type: Article

DOI: 10.1186/S13058-019-1196-Y GOOGLE SCHOLAR lock_openOpen access editor

Sustainable development goals

Data source: Scopus